Publication Date:
2020
abstract:
This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion.
Iris type:
1.1 Articolo in rivista
Keywords:
Cancer therapy; Clinical translation; Nanomedicine; Nanotechnology; Reproducibility
List of contributors:
Martins, Jp; das Neves, J; de la Fuente, M; Celia, C; Florindo, H; Günday-Türeli, N; Popat, A; Santos, Jl; Sousa, F; Schmid, R; Wolfram, J; Sarmento, B; Santos, Ha.
Published in: